Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Evommune Inc (NYSE: EVMN) closed the day trading at $16.2 up 0.75% from the previous closing price of $16.08. In other words, the price has increased by $0.75 from its previous closing price. On the day, 0.5 million shares were traded. EVMN stock price reached its highest trading level at $16.98 during the session, while it also had its lowest trading level at $15.9.
Ratios:
For a better understanding of EVMN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.76 and its Current Ratio is at 7.76.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on January 06, 2026, initiated with a Buy rating and assigned the stock a target price of $35.
On December 01, 2025, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $36.Morgan Stanley initiated its Overweight rating on December 01, 2025, with a $36 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 19 ’25 when Hopfner Robert Lorne bought 1,000 shares for $17.35 per share. The transaction valued at 17,350 led to the insider holds 4,026 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVMN now has a Market Capitalization of 510690304 and an Enterprise Value of 692397312. Its current Enterprise Value per Revenue stands at 53.261 whereas that against EBITDA is -9.699.
Stock Price History:
Over the past 52 weeks, EVMN has reached a high of $24.03, while it has fallen to a 52-week low of $13.89. The 50-Day Moving Average of the stock is -12.63%, while the 200-Day Moving Average is calculated to be -12.63%.
Shares Statistics:
Over the past 3-months, EVMN traded about 234.37K shares per day on average, while over the past 10 days, EVMN traded about 245210 shares per day. A total of 31.52M shares are outstanding, with a floating share count of 17.08M. Insiders hold about 45.81% of the company’s shares, while institutions hold 12.84% stake in the company. Shares short for EVMN as of 1765756800 were 479100 with a Short Ratio of 2.04, compared to 1763078400 on 102787. Therefore, it implies a Short% of Shares Outstanding of 479100 and a Short% of Float of 1.6900001000000002.
Earnings Estimates
The market rating of Evommune Inc (EVMN) is currently shaped by the ongoing analysis conducted by 3 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.36 and low estimates of -$0.7.
Analysts are recommending an EPS of between -$3.19 and -$11.24 for the fiscal current year, implying an average EPS of -$7.18. EPS for the following year is -$2.64, with 4.0 analysts recommending between -$1.4 and -$3.35.
